Psoriasis is a chronic autoimmune condition that speeds up the skin cell cycle, leading to inflammation, scaling, and visible lesions. There are five main types of psoriasis, including Plaque ... Medscape: Alefacept for Chronic Plaque Psoriasis: A Selective Therapy With Long-Lasting Disease Remissions and an Encouraging Safety Profile In a pivotal phase 2 clinical trial of alefacept, 229 patients with chronic moderate to severe plaque psoriasis were randomized to receive an intravenous (IV) bolus of alefacept (0.025, 0.075, or ...

Understanding the Context

Alefacept for Chronic Plaque Psoriasis: A Selective Therapy With Long-Lasting Disease Remissions and an Encouraging Safety Profile FierceBiotech: Ustekinumab (CNTO 1275) Phase 3 Data Show Long-Term Improvement Of Chronic Plaque Psoriasis Ustekinumab (CNTO 1275) Phase 3 Data Show Long-Term Improvement Of Chronic Plaque Psoriasis The New England Journal of Medicine: Trial of Roflumilast Cream for Chronic Plaque Psoriasis Nasdaq: Preliminary Data from Long-Term Safety Study Support Chronic Use of ARQ-151 (Topical Roflumilast Cream) as a Potential Treatment for Plaque Psoriasis Preliminary Data from Long-Term Safety Study Support Chronic Use of ARQ-151 (Topical Roflumilast Cream) as a Potential Treatment for Plaque Psoriasis